medline.ch Onkologie Gynäkologische Tumoren

	CDK4/6 Inhibition in the Management of Metastatic HR+/HER2+ Breast Cancer: Systematic Review and Meta-analysis. Target Oncol Park D, Varda M, Yeremian S, Hwang A, Huang C. PMID: 41559355 [PubMed - as supplied by publisher]
	From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. Sci Rep Badukle H, Jawarkar RD, Shah U, Chaudhary S, Alzahrani AYA, Samad A, Al-Hussain SA, Al-Mutairi AA, Zaki MEA. PMID: 41559139 [PubMed - as supplied by publisher]
	Management and complication investigation among breast cancer patients undergoing immediate implant-based breast reconstruction: A Chinese multicenter study (CSBrS-012). Chin Med J (Engl) Li L, Zheng A, Jin F, Guo B, Chen B, Chinese Society of Breast Surgery. PMID: 41558971 [PubMed - as supplied by publisher]
	A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. Int J Gynecol Cancer Wenham RM, Buras AL, Gordon SW, Whiting J, Fridley BL, Dorman D, Apte SM, Chon HS, Shahzad MM, Randall LM, Havrilesky LJ, Davidson BA, Secord AA. PMID: 41558878 [PubMed - as supplied by publisher]
	Reconstructive surgery and immigration status among females with breast cancer. Can J Surg Lovrics O, Kirkwood D, Coroneos CJ, Pond G, Hodgson N, Doumouras AG, Bogach J, Levine M, Parvez E. PMID: 41558773 [PubMed - indexed for MEDLINE]
	Qualitative study of information needs in advanced ovarian cancer: communication among patients, caregivers and healthcare providers regarding the disease, pharmacological treatment and non-pharmacological support. BMJ Open Rubio Pérez MJ, Sánchez-Heras AB, Maximiano Alonso C, García García Y, Alfaro Oliver N, Marcos Corrales R, Rubio Renau R, Solà Marsiñach C, Bolea Bosque S, Quindós Varela M. PMID: 41558750 [PubMed - indexed for MEDLINE]
	Metabolic vulnerabilities in ovarian cancer decoding the nexus between nutrient adaptation and therapy resistance. J Adv Res Guo X, Liu Z, Li X, Zhou B, Chen J. PMID: 41558606 [PubMed - as supplied by publisher]
	A mixed methods study of psychological distress in family caregivers of ovarian cancer patients based on the ABC-X model. Eur J Oncol Nurs Xu X, Yu S, Jing M, Liu Y, Zhang W. PMID: 41558374 [PubMed - as supplied by publisher]
	Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study. Cancer Treat Res Commun Su X, Weng Y, Xiao Y, Weng L, Zeng Y, Lin W, Zhuang W. PMID: 41558225 [PubMed - as supplied by publisher]
	Basic and combined peripheral biomarkers have no predictive and prognostic value in breast cancer patients undergoing pre-operative systemic therapy. Cir Cir Karaali C, Esin H, Pala EE, Keser M, Unal OU, Ureyen O, Emiro. PMID: 41558046 [PubMed - indexed for MEDLINE]
	Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population. Obstet Gynecol Surv Chang Y, Li T, Zhou Q, Kang D, Zhu L, Yang J, Kou Q, He H, Zhou Y, Liao Q, Du J, Yu X, Zhao Y. PMID: 41557929 [PubMed - indexed for MEDLINE]
	ESGO/INCIP Guidelines for the Management of Patients With Gynecological Cancers During Pregnancy. Obstet Gynecol Surv Amant F, Planchamp F, Berveiller P, Cardonick E, De Middelaer A, Fruscio R, Fumagalli M, Johansson ALV, Lambertini M, LeJeune CL, Lok C, McCluggage WG, Poortmans P, Sienko J, Hjortshøj CS, Swierczynska M, Testa AC, Van Assche IA, Van Calsteren K, Vincent V, Versteeg C, Zagouri F, Zapardiel Ignacio, Halaska MJ. PMID: 41557928 [PubMed - indexed for MEDLINE]
	Current Treatment for Symptomatic Uterine Fibroids: Available Evidence and Therapeutic Dilemmas. Obstet Gynecol Surv De Smit NS, de Lange ME, Boomsma MF, Huirnet JAF, Hehenkamp WJK. PMID: 41557923 [PubMed - indexed for MEDLINE]
	Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation. PLoS One Chavda T, Lawal A, Sowunmi A, Adegboyega B, Alabi A, Chung CC, Shirima S, Conserve DF, Bamodu OA. PMID: 41557711 [PubMed - indexed for MEDLINE]
	Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer. PLoS One Ying K, Xue H, Du S, Wang X, Lei X. PMID: 41557635 [PubMed - indexed for MEDLINE]
	Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US. JAMA Netw Open Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP. PMID: 41557352 [PubMed - indexed for MEDLINE]
	Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications. Mol Biol Rep Gong RQ, Xu A, Huang X, Fu D. PMID: 41557096 [PubMed - in process]
	Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Res Treat Pedersini R, Moretti L, Laganà M, Schivardi G, Baluta V, Zamparini M, Conforti E, Ravanelli M, Brentegani C, Amoroso V, Grisanti S, Buizza C, Scartabellati G, Bazzoli M, Ippolito G, Pellicioli F, Farina D, Berruti A, Cosentini D. PMID: 41557073 [PubMed - indexed for MEDLINE]
	Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan-a matched cohort study. Breast Cancer Kawamura C, Iwagami M. PMID: 41557052 [PubMed - as supplied by publisher]
	Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res Treat Stabellini N, Kaur J, Owusu C, Moftakhar B, Mizukami T, de Oliveira SD, Montero AJ. PMID: 41557039 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 323241

Seite 1 von 16163

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung